Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties

Details for Australian Patent Application No. 2006299424 (hide)

Owner Auspex Pharmaceuticals, Inc.

Inventors Gant, Thomas; Sarshar, Sepehr

Agent EF WELLINGTON & CO

Pub. Number AU-A-2006299424

PCT Pub. Number WO2007/041630

Priority 60/741,316 01.12.05 US; 60/724,160 06.10.05 US

Filing date 4 October 2006

Wipo publication date 12 April 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041630 Priority application(s): WO2007/041630

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299426-Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection

2006299421-Compositions and methods for improved skin care